ImmunoBrain Checkpoint
Disease-modifying Immunotherapies for Neurodegenerative Disorders
Active
Seed
Startup
Ness Ziona
Founded 2015-02
ImmunoBrain Checkpoint (IBC) is a biopharmaceutical company focused on developing a pipeline of disease-modifying immunotherapies for neurological disorders by targeting immune checkpoint pathways. IBCs novel approach to the treatment of neurodegeneration is based on years of innovative scientific discoveries made by Prof. Michal Schwartz of the Weizmann In…
SectorHealth Tech & Life Sciences
StageSeed
Employees19
Founded2015-02
HQNess Ziona
Crunchbaseimmunobrain-checkpoint
Confidence85
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals